Gene-Tailored reflux drug shows promise for kids with uncontrolled asthma
NCT ID NCT03015610
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This study looked at whether giving children with asthma and mild acid reflux a dose of the medicine lansoprazole based on their genes could improve both conditions. 41 children aged 6 to 17 with poorly controlled asthma took part. The goal was to see if personalized dosing leads to better asthma control and fewer reflux symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Nemours Children's Specialty Care
Jacksonville, Florida, 32207, United States
Conditions
Explore the condition pages connected to this study.